Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hextar Healthcare BhdXKLS:7803 Receivables Turnover is 1.80 as of Mar. 2026. The stock has 3 warning signs investors should review. Among 1,577 Chemicals companies, Hextar Healthcare Bhd ranks worse than 71.66% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Hextar Healthcare Bhd's Revenue for the
three
months ended in Mar. 2026 was RM31.0 Mil. Hextar Healthcare Bhd's average Accounts Receivable for the
three
months ended in Mar. 2026 was RM17.2 Mil.
Hence, Hextar Healthcare Bhd's Receivables Turnover for the
three
months ended in Mar. 2026 was 1.80.
Hextar Healthcare Bhd (XKLS:7803) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Hextar Healthcare Bhd Receivables Turnover Related Terms
Hextar Healthcare Bhd Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Hextar Healthcare Bhd's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:7803 vs LIN, SHW, ECL: Receivables Turnover Comparison
For the Specialty Chemicals subindustry, Hextar Healthcare Bhd's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hextar Healthcare Bhd Receivables Turnover vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Hextar Healthcare Bhd's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Hextar Healthcare Bhd's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hextar Healthcare Bhd (XKLS:7803) has a Receivables Turnover of 1.80 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Hextar Healthcare Bhd and its competitors. According to the industry distribution chart, Hextar Healthcare Bhd ranks #1130 out of 1577 companies in the Chemicals industry, placing it in the top 71.7%.
Is Hextar Healthcare Bhd's Receivables Turnover too high?
Hextar Healthcare Bhd's current Receivables Turnover is 1.80. The Chemicals industry median Receivables Turnover is 5.59. Hextar Healthcare Bhd's value of 1.80 is 67.8% below this industry median. Based on the distribution chart, Hextar Healthcare Bhd ranks #1130 out of 1577 companies in the Chemicals industry, which is below the industry midpoint.
How does Hextar Healthcare Bhd's Receivables Turnover compare to LIN and SHW?
According to the Chemicals industry distribution chart, Hextar Healthcare Bhd ranks #1130 out of 1577 companies for Receivables Turnover. This places Hextar Healthcare Bhd in the lower half of its industry. The industry median Receivables Turnover is 5.59. Hextar Healthcare Bhd's value of 1.80 is 67.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Chemicals company?
The median Receivables Turnover among Chemicals companies is 5.59, based on 1,577 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hextar Healthcare Bhd's current Receivables Turnover of 1.80 is 67.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Hextar Healthcare Bhd and its competitors. For the Chemicals industry, the median Receivables Turnover is 5.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hextar Healthcare Bhd's current Receivables Turnover is 1.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hextar Healthcare Bhd stock overvalued right now?
Based on GuruFocus' analysis, Hextar Healthcare Bhd (XKLS:7803) is currently considered Possible Value Trap. The stock's GF Value™ is RM0.16, compared to a current price of RM0.06 — trading 65.6% below its estimated fair value. The current Receivables Turnover is 1.80 and 67.8% below the Chemicals industry median of 5.59. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Hextar Healthcare Bhd (XKLS:7803), the current Receivables Turnover is 1.80 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Hextar Healthcare Bhd is principally involved in investment holding. Through its subsidiaries, it manufactures and sells rubber gloves. The company offers a wide range of industrial and safety gloves, household rubber gloves, and disposable vinyl and nitrile gloves. The company operates in three segments: Gloves operation, Medical devices operation, and Investment holding. The company generates the majority of its revenue from the Gloves operation segment. It has operations in Europe, Asia, North and South America, and the Rest of the world.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:7803 has been successfully added to your 
